Core 1: Pathology Core
核心 1:病理学核心
基本信息
- 批准号:10251112
- 负责人:
- 金额:$ 21.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-22 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:ArchivesAscitesAwardBackBasic ScienceBenignBiopsy SpecimenBloodBlood specimenCancer CenterChargeClinicalClinical DataClinical ResearchCodeCollectionConfidentiality of Patient InformationConsultDatabasesDevelopmentDiagnosisDisease MarkerDoctor of MedicineEndometriumEvaluationExperimental DesignsFeasibility StudiesFemale Genital NeoplasmsFormalinFreezingFrozen SectionsFundingGenerationsGenesGoalsHumanImmunohistochemistryIn Situ HybridizationIndividualInternetIntranetLaboratoriesLaboratory ResearchLinkLiquid substanceMalignant neoplasm of ovaryMammalian OviductsMicrodissectionMicroscopicMucous MembraneMusNormal tissue morphologyOperative Surgical ProceduresOvarianOvarian DiseasesOvaryParaffin EmbeddingPathologicPathologistPathologyPatientsPelvisPopulation ResearchPopulation StudyProcessPrognostic MarkerRecurrenceResearchResearch PersonnelResearch Project GrantsResearch ProposalsResearch SupportResourcesRiskSamplingSecurityServicesSlideSolid NeoplasmSourceSpecimenTechnologyTestingTissue BanksTissue EmbeddingTissue MicroarrayTissue SampleTissuesTranslational ResearchTumor BankTumor TissueUrinebasecareerdata accessdiagnostic biomarkerearly detection biomarkersexperienceexperimental studynovelpatient derived xenograft modelquality assuranceranpirnaserepositorytumorvirtual
项目摘要
Core 1: Pathology SUMMARY/ ABSTRACT
The individual research projects comprising this Ovarian Cancer SPORE application require the procurement,
processing, and analysis of histopathological material from patients with ovarian cancer and benign ovarian
diseases. The research projects have needs for frozen and formalin-fixed, paraffin-embedded samples of
tumor and normal tissue. The proposed Pathology Core augments the already established MD Anderson
Cancer Center Gynecological Tumor Bank and the P30-sponsored MD Anderson Cancer Center Centralized
Tissue Repository with supporting database and intranet access. The Core provides for tissue acquisition by
experienced gynecological pathologists to assure high-quality tissues for the investigators participating in this
SPORE as well as investigators of other SPOREs.
The goal of the Pathology Core is to provide frozen tissue, paraffin-embedded tissue, and histopathological
expertise related to the specific needs of the research projects comprising this SPORE proposal. To achieve
this goal, the Pathology Core proposes the following Specific Aims: Aim 1 is to maintain a frozen and
paraffin-embedded tissue repository of ovarian cancer, benign ovarian processes, and normal ovary. The
primary tissue source will be operative and biopsy specimens submitted to the Department of Pathology at MD
Anderson Cancer Center. Aim 2 is to provide pathological review for all clinical specimens utilized in the
SPORE projects and to provide histopathological technical services as necessary. Such technical services
include immunohistochemistry, in situ hybridization, creation of specific tissue microarray slides, pathological
evaluation of mouse tumors, and microdissection of tissue sections. Aim 3 is to establish a blood/urine/ascites
fluid repository from patients undergoing surgery for ovarian cancer and benign ovarian processes. These
fluids will provide the resources for the testing of putative prognostic and diagnostic markers derived from
experiments in the SPORE projects. Aim 4 is to create and maintain a relational SPORE Database for all
samples collected by the Pathology Core. This SPORE Database will provide for a virtual tissue repository that
can be shared electronically with all SPORE investigators.
核心1:病理学总结/摘要
包括卵巢癌孢子应用程序的个人研究项目需要采购,
卵巢癌和良性卵巢癌患者的组织病理学材料的处理和分析
疾病研究项目需要冷冻和福尔马林固定,石蜡包埋的样本,
肿瘤和正常组织。拟议的病理学核心增强了已经建立的MD安德森
癌症中心妇科肿瘤库和P30赞助的MD安德森癌症中心集中
组织储存库,支持数据库和内联网访问。核心通过以下方式提供组织采集
经验丰富的妇科病理学家,以确保高质量的组织,为研究者参与这一
SPORE以及其他SPORE的调查人员。
病理学核心的目标是提供冷冻组织、石蜡包埋组织和组织病理学检查。
与包括本SPORE提案的研究项目的特定需求相关的专业知识。实现
为了实现这一目标,病理学核心提出了以下具体目标:目标1是保持冷冻,
卵巢癌、良性卵巢过程和正常卵巢的石蜡包埋组织库。的
主要组织来源将是提交给MD病理科的手术和活检标本
安德森癌症中心。目的2是为所有临床标本提供病理学检查,
在必要时提供组织病理学技术服务。此类技术服务
包括免疫组织化学、原位杂交、产生特异性组织微阵列载玻片、病理
小鼠肿瘤的评价和组织切片的显微切割。目的3是建立血液/尿液/腹水
来自接受卵巢癌和良性卵巢过程手术的患者的液体储存库。这些
液体将提供资源,用于检测推定的预后和诊断标志物,
在SPORE项目中进行实验。目标4是为所有人创建和维护一个关系型SPORE数据库
病理学中心收集的样本该SPORE数据库将提供一个虚拟组织库,
可以通过电子方式与所有SPORE调查人员共享。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JINSONG LIU其他文献
JINSONG LIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JINSONG LIU', 18)}}的其他基金
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
- 批准号:
8053814 - 财政年份:2008
- 资助金额:
$ 21.48万 - 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
- 批准号:
7810639 - 财政年份:2008
- 资助金额:
$ 21.48万 - 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
- 批准号:
7534226 - 财政年份:2008
- 资助金额:
$ 21.48万 - 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号传导、衰老成纤维细胞和卵巢癌进展
- 批准号:
7631233 - 财政年份:2008
- 资助金额:
$ 21.48万 - 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
- 批准号:
8240516 - 财政年份:2008
- 资助金额:
$ 21.48万 - 项目类别:
相似海外基金
Analyses of immune response and bacteria in cirrhotic ascites with Tm mapping method.
Tm 图谱法分析肝硬化腹水中的免疫反应和细菌。
- 批准号:
20K08305 - 财政年份:2020
- 资助金额:
$ 21.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Randomized controlled trial to elucidate "would patients be weakened if ascites removed?"
随机对照试验阐明“如果腹水被清除,患者会变得虚弱吗?”
- 批准号:
20K16567 - 财政年份:2020
- 资助金额:
$ 21.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of new immuno-cell therapy for the treatment of refractory malignant ascites and pleural effusion
开发新的免疫细胞疗法治疗难治性恶性腹水和胸腔积液
- 批准号:
19K09196 - 财政年份:2019
- 资助金额:
$ 21.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ascites proteomics reveal the mechanism of pancreatic cancer peritoneal dissemination
腹水蛋白质组学揭示胰腺癌腹膜播散机制
- 批准号:
19K18107 - 财政年份:2019
- 资助金额:
$ 21.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Novel Therapy for gastrointestinal cancer targeting exosome in malignant ascites
一种针对恶性腹水中外泌体的胃肠癌新疗法
- 批准号:
18H02882 - 财政年份:2018
- 资助金额:
$ 21.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Peritoneal metastasis Prediction by exosome in washing ascites for gastric cancer
胃癌洗腹水中外泌体预测腹膜转移
- 批准号:
18K16321 - 财政年份:2018
- 资助金额:
$ 21.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
无标记微流体从腹水中的非癌细胞中富集癌细胞
- 批准号:
9251748 - 财政年份:2016
- 资助金额:
$ 21.48万 - 项目类别:
Preparation of ascites purification device for cancerous ascites and establishment of portable continuous ascites purification perfusion method
癌性腹水腹水净化装置的研制及便携式连续腹水净化灌注方法的建立
- 批准号:
16K01425 - 财政年份:2016
- 资助金额:
$ 21.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
无标记微流体从腹水中的非癌细胞中富集癌细胞
- 批准号:
9036692 - 财政年份:2016
- 资助金额:
$ 21.48万 - 项目类别:
Identifying Factors in Malignant Ascites Facilitating Gastric Adenocarcinoma Peritoneal Metastasis
确定恶性腹水促进胃腺癌腹膜转移的因素
- 批准号:
349961 - 财政年份:2015
- 资助金额:
$ 21.48万 - 项目类别:
Studentship Programs